Allergan to Build on Body Contouring Portfolio with Latest Soliton Acquisition
The Soliton acquisition adds RESONIC technology platform for improvement in appearance of cellulite, tattoo removal, and fibrotic scars.
The Soliton acquisition adds RESONIC technology platform for improvement in appearance of cellulite, tattoo removal, and fibrotic scars.
The initial launch of the RESONIC brand for tattoo and cellulite indications is expected in Q2 of 2021.
The agency has accepted the resubmission seeking approval of the neuromodulator for the temporary improvement of moderate-to-severe glabellar lines and crow’s feet in adults.